nodes	percent_of_prediction	percent_of_DWPC	metapath
Lucanthone—TOP2A—G0 and Early G1—E2F5—ocular cancer	0.0228	0.0228	CbGpPWpGaD
Lucanthone—TOP2A—G0 and Early G1—E2F4—ocular cancer	0.0224	0.0224	CbGpPWpGaD
Lucanthone—TOP2A—G0 and Early G1—MYBL2—ocular cancer	0.0224	0.0224	CbGpPWpGaD
Lucanthone—TOP2A—G0 and Early G1—RBL1—ocular cancer	0.0219	0.0219	CbGpPWpGaD
Lucanthone—TOP2A—G0 and Early G1—RBL2—ocular cancer	0.0201	0.0201	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—RBL2—ocular cancer	0.02	0.02	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 1—MYBL2—ocular cancer	0.0199	0.0199	CbGpPWpGaD
Lucanthone—TOP2A—G0 and Early G1—RBBP4—ocular cancer	0.019	0.019	CbGpPWpGaD
Lucanthone—TOP2A—G0 and Early G1—CDC25A—ocular cancer	0.0181	0.0181	CbGpPWpGaD
Lucanthone—TOP2A—G0 and Early G1—TFDP1—ocular cancer	0.0177	0.0177	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—CRTC1—ocular cancer	0.0166	0.0166	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—CCND3—ocular cancer	0.016	0.016	CbGpPWpGaD
Lucanthone—APEX1—DNA Replication—E2F2—ocular cancer	0.0152	0.0152	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—ID2—ocular cancer	0.0148	0.0148	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—E2F5—ocular cancer	0.0143	0.0143	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.0141	0.0141	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.0138	0.0138	CbGpPWpGaD
Lucanthone—APEX1—Chromosome Maintenance—RBBP4—ocular cancer	0.0138	0.0138	CbGpPWpGaD
Lucanthone—APEX1—DNA Replication—E2F3—ocular cancer	0.0132	0.0132	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—GNAQ—ocular cancer	0.0113	0.0113	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CDC25A—ocular cancer	0.0109	0.0109	CbGpPWpGaD
Lucanthone—TOP2A—G0 and Early G1—HDAC1—ocular cancer	0.0103	0.0103	CbGpPWpGaD
Lucanthone—TOP2A—G0 and Early G1—E2F1—ocular cancer	0.00845	0.00845	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—E2F1—ocular cancer	0.00841	0.00841	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—E2F2—ocular cancer	0.00809	0.00809	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—GNA11—ocular cancer	0.00741	0.00741	CbGpPWpGaD
Lucanthone—TOP2A—G0 and Early G1—CDK2—ocular cancer	0.00729	0.00729	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—CDK2—ocular cancer	0.00725	0.00725	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDKN2C—ocular cancer	0.00712	0.00712	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—RBBP4—ocular cancer	0.00702	0.00702	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—E2F3—ocular cancer	0.00702	0.00702	CbGpPWpGaD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—EP300—ocular cancer	0.00693	0.00693	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—GNAQ—ocular cancer	0.00689	0.00689	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—CDK4—ocular cancer	0.00685	0.00685	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CDC25A—ocular cancer	0.00667	0.00667	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—TFDP1—ocular cancer	0.00652	0.00652	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—HDAC1—ocular cancer	0.00621	0.00621	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—RB1—ocular cancer	0.00596	0.00596	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—E2F5—ocular cancer	0.00593	0.00593	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CCND3—ocular cancer	0.00591	0.00591	CbGpPWpGaD
Lucanthone—APEX1—DNA Replication—E2F1—ocular cancer	0.00584	0.00584	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—E2F4—ocular cancer	0.00581	0.00581	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—MYBL2—ocular cancer	0.00581	0.00581	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.0058	0.0058	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—RBL1—ocular cancer	0.00569	0.00569	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—E2F2—ocular cancer	0.00569	0.00569	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDKN2C—ocular cancer	0.00565	0.00565	CbGpPWpGaD
Lucanthone—APEX1—Synthesis of DNA—CDK2—ocular cancer	0.00537	0.00537	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00532	0.00532	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—E2F1—ocular cancer	0.00528	0.00528	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—RBL2—ocular cancer	0.00523	0.00523	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—CRTC1—ocular cancer	0.00518	0.00518	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDKN2C—ocular cancer	0.00505	0.00505	CbGpPWpGaD
Lucanthone—APEX1—DNA Replication—CDK2—ocular cancer	0.00504	0.00504	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—E2F3—ocular cancer	0.00494	0.00494	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—RBBP4—ocular cancer	0.00494	0.00494	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—E2F5—ocular cancer	0.0047	0.0047	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDC25A—ocular cancer	0.0047	0.0047	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—CDKN1B—ocular cancer	0.00464	0.00464	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—ID2—ocular cancer	0.00462	0.00462	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—E2F4—ocular cancer	0.0046	0.0046	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—MYBL2—ocular cancer	0.0046	0.0046	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—TFDP1—ocular cancer	0.00459	0.00459	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00459	0.00459	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CDK2—ocular cancer	0.00456	0.00456	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—E2F2—ocular cancer	0.00452	0.00452	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—RBL1—ocular cancer	0.00452	0.00452	CbGpPWpGaD
Lucanthone—APEX1—Synthesis of DNA—RB1—ocular cancer	0.00442	0.00442	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CDK2—ocular cancer	0.00441	0.00441	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CDK6—ocular cancer	0.00441	0.00441	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.0044	0.0044	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00434	0.00434	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.00431	0.00431	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CDK4—ocular cancer	0.00431	0.00431	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—E2F5—ocular cancer	0.0042	0.0042	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CDK4—ocular cancer	0.00417	0.00417	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—CDK4—ocular cancer	0.00416	0.00416	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CCND3—ocular cancer	0.00416	0.00416	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—RBL2—ocular cancer	0.00415	0.00415	CbGpPWpGaD
Lucanthone—APEX1—DNA Replication—RB1—ocular cancer	0.00414	0.00414	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—E2F4—ocular cancer	0.00412	0.00412	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MYBL2—ocular cancer	0.00412	0.00412	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—AKT1—ocular cancer	0.0041	0.0041	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—E2F2—ocular cancer	0.00404	0.00404	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—RBL1—ocular cancer	0.00404	0.00404	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—RBBP4—ocular cancer	0.00392	0.00392	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—E2F3—ocular cancer	0.00392	0.00392	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—HDAC1—ocular cancer	0.00379	0.00379	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—RB1—ocular cancer	0.00374	0.00374	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDC25A—ocular cancer	0.00372	0.00372	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—RBL2—ocular cancer	0.00371	0.00371	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—TFDP1—ocular cancer	0.00364	0.00364	CbGpPWpGaD
Lucanthone—APEX1—S Phase—RB1—ocular cancer	0.00362	0.00362	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—MYC—ocular cancer	0.00355	0.00355	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—E2F3—ocular cancer	0.0035	0.0035	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—RBBP4—ocular cancer	0.0035	0.0035	CbGpPWpGaD
Lucanthone—APEX1—Synthesis of DNA—CDKN1B—ocular cancer	0.00344	0.00344	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDC25A—ocular cancer	0.00333	0.00333	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CCND3—ocular cancer	0.0033	0.0033	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TFDP1—ocular cancer	0.00325	0.00325	CbGpPWpGaD
Lucanthone—APEX1—DNA Replication—CDKN1B—ocular cancer	0.00322	0.00322	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.00322	0.00322	CbGpPWpGaD
Lucanthone—APEX1—Synthesis of DNA—CDKN1A—ocular cancer	0.00317	0.00317	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—E2F1—ocular cancer	0.00312	0.00312	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDK6—ocular cancer	0.0031	0.0031	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—ocular cancer	0.00308	0.00308	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—MYC—ocular cancer	0.00301	0.00301	CbGpPWpGaD
Lucanthone—APEX1—DNA Replication—CDKN1A—ocular cancer	0.00298	0.00298	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CCND3—ocular cancer	0.00295	0.00295	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.00294	0.00294	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CDKN1B—ocular cancer	0.00291	0.00291	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CDKN1B—ocular cancer	0.00282	0.00282	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.0028	0.0028	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—HRAS—ocular cancer	0.00279	0.00279	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CCND1—ocular cancer	0.00278	0.00278	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.00271	0.00271	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CCND1—ocular cancer	0.00269	0.00269	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CDK2—ocular cancer	0.00269	0.00269	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CCND2—ocular cancer	0.00267	0.00267	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—HDAC1—ocular cancer	0.00267	0.00267	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDKN2C—ocular cancer	0.00261	0.00261	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CDKN1A—ocular cancer	0.0026	0.0026	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.00258	0.00258	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—ocular cancer	0.00254	0.00254	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—EP300—ocular cancer	0.00247	0.00247	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—TP53—ocular cancer	0.00247	0.00247	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—AKT1—ocular cancer	0.00246	0.00246	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDK6—ocular cancer	0.00246	0.00246	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDKN2B—ocular cancer	0.00239	0.00239	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDKN2C—ocular cancer	0.00234	0.00234	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—GNA11—ocular cancer	0.00231	0.00231	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.00225	0.00225	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.00224	0.00224	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—MYC—ocular cancer	0.00223	0.00223	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TGFB1—ocular cancer	0.00223	0.00223	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—RB1—ocular cancer	0.00221	0.00221	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDK6—ocular cancer	0.0022	0.0022	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—E2F1—ocular cancer	0.00219	0.00219	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—E2F5—ocular cancer	0.00217	0.00217	CbGpPWpGaD
Lucanthone—APEX1—S Phase—MYC—ocular cancer	0.00216	0.00216	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—GNAQ—ocular cancer	0.00215	0.00215	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—E2F4—ocular cancer	0.00213	0.00213	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—MYBL2—ocular cancer	0.00213	0.00213	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CCND2—ocular cancer	0.00211	0.00211	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.00211	0.00211	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—E2F2—ocular cancer	0.00209	0.00209	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—RBL1—ocular cancer	0.00209	0.00209	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—E2F5—ocular cancer	0.00194	0.00194	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—HDAC1—ocular cancer	0.00194	0.00194	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—RBL2—ocular cancer	0.00192	0.00192	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—E2F4—ocular cancer	0.0019	0.0019	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MYBL2—ocular cancer	0.0019	0.0019	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.0019	0.0019	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDK2—ocular cancer	0.00189	0.00189	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CCND2—ocular cancer	0.00189	0.00189	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—HDAC1—ocular cancer	0.00189	0.00189	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—ocular cancer	0.00188	0.00188	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—E2F2—ocular cancer	0.00187	0.00187	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—RBL1—ocular cancer	0.00187	0.00187	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.00184	0.00184	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TP53—ocular cancer	0.00183	0.00183	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—RBBP4—ocular cancer	0.00181	0.00181	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—E2F3—ocular cancer	0.00181	0.00181	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00181	0.00181	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDK4—ocular cancer	0.00179	0.00179	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—TP53—ocular cancer	0.00177	0.00177	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—E2F1—ocular cancer	0.00174	0.00174	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDC25A—ocular cancer	0.00172	0.00172	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—ocular cancer	0.00172	0.00172	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—RBL2—ocular cancer	0.00171	0.00171	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDKN2B—ocular cancer	0.00169	0.00169	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—TFDP1—ocular cancer	0.00168	0.00168	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00166	0.00166	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	0.00164	0.00164	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—RBBP4—ocular cancer	0.00162	0.00162	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—E2F3—ocular cancer	0.00162	0.00162	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	0.00159	0.00159	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.00156	0.00156	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—E2F1—ocular cancer	0.00156	0.00156	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—RB1—ocular cancer	0.00155	0.00155	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDC25A—ocular cancer	0.00154	0.00154	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CCND3—ocular cancer	0.00153	0.00153	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TFDP1—ocular cancer	0.00151	0.00151	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDK2—ocular cancer	0.0015	0.0015	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00143	0.00143	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDK4—ocular cancer	0.00142	0.00142	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CCND3—ocular cancer	0.00136	0.00136	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00135	0.00135	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDK2—ocular cancer	0.00134	0.00134	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.00132	0.00132	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—CDK4—ocular cancer	0.0013	0.0013	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDK4—ocular cancer	0.00127	0.00127	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—RB1—ocular cancer	0.00123	0.00123	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDKN1B—ocular cancer	0.00121	0.00121	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CCND1—ocular cancer	0.00115	0.00115	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDK6—ocular cancer	0.00114	0.00114	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDKN1A—ocular cancer	0.00112	0.00112	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—RB1—ocular cancer	0.0011	0.0011	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.00108	0.00108	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDK6—ocular cancer	0.00102	0.00102	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.001	0.001	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CCND2—ocular cancer	0.000978	0.000978	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.000978	0.000978	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.00096	0.00096	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MDM2—ocular cancer	0.00094	0.00094	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—MYC—ocular cancer	0.000926	0.000926	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000917	0.000917	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000916	0.000916	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.000886	0.000886	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.000877	0.000877	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000875	0.000875	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CCND2—ocular cancer	0.000874	0.000874	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—HDAC1—ocular cancer	0.000874	0.000874	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDKN1B—ocular cancer	0.000858	0.000858	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000846	0.000846	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—EP300—ocular cancer	0.000843	0.000843	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CCND1—ocular cancer	0.000819	0.000819	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000805	0.000805	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—E2F1—ocular cancer	0.000805	0.000805	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDKN1A—ocular cancer	0.000792	0.000792	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDKN2B—ocular cancer	0.000784	0.000784	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—EP300—ocular cancer	0.000773	0.000773	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—EP300—ocular cancer	0.000754	0.000754	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—MYC—ocular cancer	0.000735	0.000735	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—E2F1—ocular cancer	0.000719	0.000719	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000702	0.000702	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.0007	0.0007	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDK2—ocular cancer	0.000694	0.000694	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MYC—ocular cancer	0.000657	0.000657	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDK4—ocular cancer	0.000656	0.000656	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDK2—ocular cancer	0.00062	0.00062	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDK4—ocular cancer	0.000586	0.000586	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000576	0.000576	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—RB1—ocular cancer	0.00057	0.00057	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—TP53—ocular cancer	0.000553	0.000553	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TP53—ocular cancer	0.000539	0.000539	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—RB1—ocular cancer	0.00051	0.00051	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000487	0.000487	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.000444	0.000444	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MDM2—ocular cancer	0.000435	0.000435	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000424	0.000424	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.00041	0.00041	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDKN1B—ocular cancer	0.000397	0.000397	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—EP300—ocular cancer	0.00039	0.00039	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CCND1—ocular cancer	0.000379	0.000379	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDKN1A—ocular cancer	0.000366	0.000366	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—EP300—ocular cancer	0.000349	0.000349	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—MYC—ocular cancer	0.00034	0.00034	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MYC—ocular cancer	0.000304	0.000304	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TP53—ocular cancer	0.000249	0.000249	CbGpPWpGaD
